-+ 0.00%
-+ 0.00%
-+ 0.00%

AbCellera Biologics Q4 Earnings Report: What Investors Need to Know

Benzinga·02/24/2026 21:22:10
Listen to the news

The Q4 earnings report for AbCellera Biologics (NASDAQ:ABCL) was released on Tuesday, February 24, 2026 at 04:05 PM.

Here's what investors need to know about the latest announcement.

Earnings

AbCellera Biologics beat estimated earnings by 83.33%, reporting an EPS of $-0.03 versus an estimate of $-0.18.

Revenue was up $39.80 million from the same period last year.

Earnings History Overview

The company missed on EPS by $0.02 in the last quarter, resulting in a 13.69% drop share price change the following day.

Here's a look at AbCellera Biologics's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -0.17 -0.17 -0.14 -0.15
EPS Actual -0.19 -0.12 -0.15 -0.12
Revenue Estimate 6.45M 6.58M 7.12M 7.58M
Revenue Actual 8.96M 17.08M 4.24M 5.10M

To track all earnings releases for AbCellera Biologics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.